APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Raw Material Testing Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Raw Material Testing Service Market Outlook and Growth Opportunities 2026

Report ID 174214500416 January 2026194 pages

Choose your research edition.

Industry ResearchPharmaceutical Raw Material Testing Service Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Raw Material Testing Service Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Raw Material Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Raw Material Testing Service Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Raw Material Testing Service Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Pharmaceutical Raw Material Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical Raw Material Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Raw Material Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Raw Material Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical Raw Material Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical Raw Material Testing Service market include ARBRO, Boston Analytical, CPT Labs, Element, Eurofins Scientific, Intertek, Nelson Labs, Pace Analytical and SGS Group, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmaceutical Raw Material Testing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Raw Material Testing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Raw Material Testing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical Raw Material Testing Service market.

Pharmaceutical Raw Material Testing Service Segment by Company

ARBRO

Boston Analytical

CPT Labs

Element

Eurofins Scientific

Intertek

Nelson Labs

Pace Analytical

SGS Group

Tepnel

TÜV SUD

Pharmaceutical Raw Material Testing Service Segment by Type

Pharmaceutical Substances

Intermediates

Excipients

Other

Pharmaceutical Raw Material Testing Service Segment by Application

Pharmaceutical

Bio-pharmacy

Other

Pharmaceutical Raw Material Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical Raw Material Testing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmaceutical Raw Material Testing Service key companies, revenue, market share, and recent developments.

3. To split the Pharmaceutical Raw Material Testing Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmaceutical Raw Material Testing Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Raw Material Testing Service significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Raw Material Testing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Raw Material Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Raw Material Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Raw Material Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Raw Material Testing Service industry.

Chapter 3: Detailed analysis of Pharmaceutical Raw Material Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmaceutical Raw Material Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmaceutical Raw Material Testing Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Raw Material Testing Service Industry Trends Table 2. Pharmaceutical Raw Material Testing Service Industry Drivers Table 3. Pharmaceutical Raw Material Testing Service Industry Opportunities and Challenges Table 4. Pharmaceutical Raw Material Testing Service Industry Restraints Table 5. Global Pharmaceutical Raw Material Testing Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Raw Material Testing Service Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Raw Material Testing Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmaceutical Raw Material Testing Service Key Company Manufacturing Base & Headquarters Table 9. Global Pharmaceutical Raw Material Testing Service Company, Product Type & Application Table 10. Global Pharmaceutical Raw Material Testing Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmaceutical Raw Material Testing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Pharmaceutical Substances Table 15. Significant Companies of Intermediates Table 16. Significant Companies of Excipients Table 17. Significant Companies of Other Table 18. Global Pharmaceutical Raw Material Testing Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Pharmaceutical Raw Material Testing Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Pharmaceutical Raw Material Testing Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Pharmaceutical Raw Material Testing Service Sales Value Share by Type (2021-2026) Table 22. Global Pharmaceutical Raw Material Testing Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Pharmaceutical Table 24. Significant Companies of Bio-pharmacy Table 25. Significant Companies of Other Table 26. Global Pharmaceutical Raw Material Testing Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pharmaceutical Raw Material Testing Service Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Pharmaceutical Raw Material Testing Service Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Pharmaceutical Raw Material Testing Service Sales Value Share by Application (2021-2026) Table 30. Global Pharmaceutical Raw Material Testing Service Sales Value Share by Application (2027-2032) Table 31. Global Pharmaceutical Raw Material Testing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pharmaceutical Raw Material Testing Service Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Pharmaceutical Raw Material Testing Service Sales Value Share by Region (2021-2026) Table 34. Global Pharmaceutical Raw Material Testing Service Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Pharmaceutical Raw Material Testing Service Sales Value Share by Region (2027-2032) Table 36. Global Pharmaceutical Raw Material Testing Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Pharmaceutical Raw Material Testing Service Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Pharmaceutical Raw Material Testing Service Sales Value Market Share by Country (2021-2026) Table 39. Global Pharmaceutical Raw Material Testing Service Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Pharmaceutical Raw Material Testing Service Sales Value Market Share by Country (2027-2032) Table 41. ARBRO Company Information Table 42. ARBRO Business Overview Table 43. ARBRO Pharmaceutical Raw Material Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. ARBRO Pharmaceutical Raw Material Testing Service Product Portfolio Table 45. ARBRO Recent Development Table 46. Boston Analytical Company Information Table 47. Boston Analytical Business Overview Table 48. Boston Analytical Pharmaceutical Raw Material Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Boston Analytical Pharmaceutical Raw Material Testing Service Product Portfolio Table 50. Boston Analytical Recent Development Table 51. CPT Labs Company Information Table 52. CPT Labs Business Overview Table 53. CPT Labs Pharmaceutical Raw Material Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. CPT Labs Pharmaceutical Raw Material Testing Service Product Portfolio Table 55. CPT Labs Recent Development Table 56. Element Company Information Table 57. Element Business Overview Table 58. Element Pharmaceutical Raw Material Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Element Pharmaceutical Raw Material Testing Service Product Portfolio Table 60. Element Recent Development Table 61. Eurofins Scientific Company Information Table 62. Eurofins Scientific Business Overview Table 63. Eurofins Scientific Pharmaceutical Raw Material Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Eurofins Scientific Pharmaceutical Raw Material Testing Service Product Portfolio Table 65. Eurofins Scientific Recent Development Table 66. Intertek Company Information Table 67. Intertek Business Overview Table 68. Intertek Pharmaceutical Raw Material Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Intertek Pharmaceutical Raw Material Testing Service Product Portfolio Table 70. Intertek Recent Development Table 71. Nelson Labs Company Information Table 72. Nelson Labs Business Overview Table 73. Nelson Labs Pharmaceutical Raw Material Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Nelson Labs Pharmaceutical Raw Material Testing Service Product Portfolio Table 75. Nelson Labs Recent Development Table 76. Pace Analytical Company Information Table 77. Pace Analytical Business Overview Table 78. Pace Analytical Pharmaceutical Raw Material Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Pace Analytical Pharmaceutical Raw Material Testing Service Product Portfolio Table 80. Pace Analytical Recent Development Table 81. SGS Group Company Information Table 82. SGS Group Business Overview Table 83. SGS Group Pharmaceutical Raw Material Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. SGS Group Pharmaceutical Raw Material Testing Service Product Portfolio Table 85. SGS Group Recent Development Table 86. Tepnel Company Information Table 87. Tepnel Business Overview Table 88. Tepnel Pharmaceutical Raw Material Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Tepnel Pharmaceutical Raw Material Testing Service Product Portfolio Table 90. Tepnel Recent Development Table 91. TÜV SUD Company Information Table 92. TÜV SUD Business Overview Table 93. TÜV SUD Pharmaceutical Raw Material Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. TÜV SUD Pharmaceutical Raw Material Testing Service Product Portfolio Table 95. TÜV SUD Recent Development Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Pharmaceutical Raw Material Testing Service Product Image Figure 2. Global Pharmaceutical Raw Material Testing Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Raw Material Testing Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Raw Material Testing Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Pharmaceutical Substances Image Figure 8. Intermediates Image Figure 9. Excipients Image Figure 10. Other Image Figure 11. Global Pharmaceutical Raw Material Testing Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Pharmaceutical Raw Material Testing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Pharmaceutical Raw Material Testing Service Sales Value Share by Type (2021-2032) Figure 14. Pharmaceutical Image Figure 15. Bio-pharmacy Image Figure 16. Other Image Figure 17. Global Pharmaceutical Raw Material Testing Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pharmaceutical Raw Material Testing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Pharmaceutical Raw Material Testing Service Sales Value Share by Application (2021-2032) Figure 20. Global Pharmaceutical Raw Material Testing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Pharmaceutical Raw Material Testing Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Pharmaceutical Raw Material Testing Service Sales Value (2021-2032) & (US$ Million) Figure 23. North America Pharmaceutical Raw Material Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Pharmaceutical Raw Material Testing Service Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Pharmaceutical Raw Material Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Pharmaceutical Raw Material Testing Service Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Pharmaceutical Raw Material Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Pharmaceutical Raw Material Testing Service Sales Value (2021-2032) & (US$ Million) Figure 29. South America Pharmaceutical Raw Material Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Pharmaceutical Raw Material Testing Service Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Pharmaceutical Raw Material Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmaceutical Substances
  • Intermediates
  • Excipients
  • Other
Applications
  • Pharmaceutical
  • Bio-pharmacy
  • Other
Companies covered
  • ARBRO
  • Boston Analytical
  • CPT Labs
  • Element
  • Eurofins Scientific
  • Intertek
  • Nelson Labs
  • Pace Analytical
  • SGS Group
  • Tepnel
  • TÜV SUD

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical Raw Material Testing Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical Raw Material Testing Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmaceutical Raw Material Testing Service Market Dynamics
  1. 2.1 Pharmaceutical Raw Material Testing Service Industry Trends
  2. 2.2 Pharmaceutical Raw Material Testing Service Industry Drivers
  3. 2.3 Pharmaceutical Raw Material Testing Service Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Raw Material Testing Service Industry Restraints
3 Pharmaceutical Raw Material Testing Service Market by Company
  1. 3.1 Global Pharmaceutical Raw Material Testing Service Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Raw Material Testing Service Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Raw Material Testing Service Company Ranking (2024-2026)
  4. 3.4 Global Pharmaceutical Raw Material Testing Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmaceutical Raw Material Testing Service Company Product Type and Application
  6. 3.6 Global Pharmaceutical Raw Material Testing Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmaceutical Raw Material Testing Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmaceutical Raw Material Testing Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical Raw Material Testing Service Market by Type
  1. 4.1 Pharmaceutical Raw Material Testing Service Type Introduction
  2. 4.1.1 Pharmaceutical Substances
  3. 4.1.2 Intermediates
  4. 4.1.3 Excipients
  5. 4.1.4 Other
  6. 4.2 Global Pharmaceutical Raw Material Testing Service Sales Value by Type
  7. 4.2.1 Global Pharmaceutical Raw Material Testing Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pharmaceutical Raw Material Testing Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global Pharmaceutical Raw Material Testing Service Sales Value Share by Type (2021-2032)
5 Pharmaceutical Raw Material Testing Service Market by Application
  1. 5.1 Pharmaceutical Raw Material Testing Service Application Introduction
  2. 5.1.1 Pharmaceutical
  3. 5.1.2 Bio-pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Pharmaceutical Raw Material Testing Service Sales Value by Application
  6. 5.2.1 Global Pharmaceutical Raw Material Testing Service Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmaceutical Raw Material Testing Service Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pharmaceutical Raw Material Testing Service Sales Value Share by Application (2021-2032)
6 Pharmaceutical Raw Material Testing Service Regional Value Analysis
  1. 6.1 Global Pharmaceutical Raw Material Testing Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Raw Material Testing Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Raw Material Testing Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Raw Material Testing Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical Raw Material Testing Service Sales Value (2021-2032)
  7. 6.3.2 North America Pharmaceutical Raw Material Testing Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmaceutical Raw Material Testing Service Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmaceutical Raw Material Testing Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmaceutical Raw Material Testing Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmaceutical Raw Material Testing Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmaceutical Raw Material Testing Service Sales Value (2021-2032)
  16. 6.6.2 South America Pharmaceutical Raw Material Testing Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmaceutical Raw Material Testing Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmaceutical Raw Material Testing Service Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Raw Material Testing Service Country-level Value Analysis
  1. 7.1 Global Pharmaceutical Raw Material Testing Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Raw Material Testing Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmaceutical Raw Material Testing Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmaceutical Raw Material Testing Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmaceutical Raw Material Testing Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmaceutical Raw Material Testing Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmaceutical Raw Material Testing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ARBRO
  2. 8.1.1 ARBRO Company Information
  3. 8.1.2 ARBRO Business Overview
  4. 8.1.3 ARBRO Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ARBRO Pharmaceutical Raw Material Testing Service Product Portfolio
  6. 8.1.5 ARBRO Recent Developments
  7. 8.2 Boston Analytical
  8. 8.2.1 Boston Analytical Company Information
  9. 8.2.2 Boston Analytical Business Overview
  10. 8.2.3 Boston Analytical Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boston Analytical Pharmaceutical Raw Material Testing Service Product Portfolio
  12. 8.2.5 Boston Analytical Recent Developments
  13. 8.3 CPT Labs
  14. 8.3.1 CPT Labs Company Information
  15. 8.3.2 CPT Labs Business Overview
  16. 8.3.3 CPT Labs Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CPT Labs Pharmaceutical Raw Material Testing Service Product Portfolio
  18. 8.3.5 CPT Labs Recent Developments
  19. 8.4 Element
  20. 8.4.1 Element Company Information
  21. 8.4.2 Element Business Overview
  22. 8.4.3 Element Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Element Pharmaceutical Raw Material Testing Service Product Portfolio
  24. 8.4.5 Element Recent Developments
  25. 8.5 Eurofins Scientific
  26. 8.5.1 Eurofins Scientific Company Information
  27. 8.5.2 Eurofins Scientific Business Overview
  28. 8.5.3 Eurofins Scientific Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Eurofins Scientific Pharmaceutical Raw Material Testing Service Product Portfolio
  30. 8.5.5 Eurofins Scientific Recent Developments
  31. 8.6 Intertek
  32. 8.6.1 Intertek Company Information
  33. 8.6.2 Intertek Business Overview
  34. 8.6.3 Intertek Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Intertek Pharmaceutical Raw Material Testing Service Product Portfolio
  36. 8.6.5 Intertek Recent Developments
  37. 8.7 Nelson Labs
  38. 8.7.1 Nelson Labs Company Information
  39. 8.7.2 Nelson Labs Business Overview
  40. 8.7.3 Nelson Labs Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nelson Labs Pharmaceutical Raw Material Testing Service Product Portfolio
  42. 8.7.5 Nelson Labs Recent Developments
  43. 8.8 Pace Analytical
  44. 8.8.1 Pace Analytical Company Information
  45. 8.8.2 Pace Analytical Business Overview
  46. 8.8.3 Pace Analytical Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pace Analytical Pharmaceutical Raw Material Testing Service Product Portfolio
  48. 8.8.5 Pace Analytical Recent Developments
  49. 8.9 SGS Group
  50. 8.9.1 SGS Group Company Information
  51. 8.9.2 SGS Group Business Overview
  52. 8.9.3 SGS Group Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 SGS Group Pharmaceutical Raw Material Testing Service Product Portfolio
  54. 8.9.5 SGS Group Recent Developments
  55. 8.10 Tepnel
  56. 8.10.1 Tepnel Company Information
  57. 8.10.2 Tepnel Business Overview
  58. 8.10.3 Tepnel Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Tepnel Pharmaceutical Raw Material Testing Service Product Portfolio
  60. 8.10.5 Tepnel Recent Developments
  61. 8.11 TÜV SUD
  62. 8.11.1 TÜV SUD Company Information
  63. 8.11.2 TÜV SUD Business Overview
  64. 8.11.3 TÜV SUD Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 TÜV SUD Pharmaceutical Raw Material Testing Service Product Portfolio
  66. 8.11.5 TÜV SUD Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst